Physician

Natakom Nash Chulamorkodt, MD

According to 2025 Medicare claims, Natakom Chulamorkodt, MD (NPI: 1043388481) practices urology in the Yuma, AZ market, with the plurality of this provider's patient population coming from Yuma, AZ. This provider's primary affiliated billing organization is YUMA UROLOGY CENTER PLLC (NPI: 1841482577; TIN: 208879735) and primary practice location at 85364-6258. Chulamorkodt is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Chulamorkodt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 747 traditional Medicare patients, billed 4,306 HCPCS/CPT codes, and received $304,259 in Medicare payments. The top billing code was 52224 (Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm). Part D data shows 5,823 prescription claims across 1,212 beneficiaries totaling $495,301 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 90 claims. Open Payments data shows 2 records totaling $48. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $164,048 to $495,301. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$234K$467K2015 Medicare payment: $391,274 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $467,222 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $420,311 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $450,973 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $403,482 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $318,621 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $387,002 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $388,527 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $370,010 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $304,259 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2276,829$391,274
20161,3457,359$467,222
20171,3616,834$420,311
20181,3536,747$450,973
20191,1615,810$403,482
20208745,170$318,621
20218315,466$387,002
20227995,218$388,527
20238244,834$370,010
20247474,306$304,259

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$248K$495K2015 Drug cost: $164,048 (USD; Tot_Drug_Cst)2016 Drug cost: $191,107 (USD; Tot_Drug_Cst)2017 Drug cost: $226,070 (USD; Tot_Drug_Cst)2018 Drug cost: $230,389 (USD; Tot_Drug_Cst)2019 Drug cost: $168,449 (USD; Tot_Drug_Cst)2020 Drug cost: $171,187 (USD; Tot_Drug_Cst)2021 Drug cost: $241,042 (USD; Tot_Drug_Cst)2022 Drug cost: $308,810 (USD; Tot_Drug_Cst)2023 Drug cost: $480,818 (USD; Tot_Drug_Cst)2024 Drug cost: $495,301 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155122,118$164,048
20165782,476$191,107
20176942,792$226,070
20187422,817$230,389
20198282,896$168,449
20208653,598$171,187
20219414,135$241,042
20229233,974$308,810
20231,0824,897$480,818
20241,2125,823$495,301

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$31K$62K2015 Medicare payment: $26,927 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $27,170 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $39,014 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $40,390 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $45,108 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $47,804 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $44,609 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $45,516 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $51,984 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $62,072 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151193$26,927
20161290$27,170
20171494$39,014
201815137$40,390
20191360$45,108
20201678$47,804
20211583$44,609
2022N/R97$45,516
2023N/R100$51,984
2024N/R90$62,072

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
52224Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm116120$588
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more222222$108
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6611,705$91
51798Ultrasound measurement of bladder capacity after voiding561900$8
81002Urinalysis, manual test479745$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MyrbetriqMirabegron25719,180$277,005
Tamsulosin HclTamsulosin Hcl2,299183,739$80,929
Mirabegron ErMirabegron494,020$40,849
FinasterideFinasteride99579,687$19,520
Oxybutynin ChlorideOxybutynin Chloride36525,716$8,714

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4352Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), eachNN/R43$38,688
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R47$23,384

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$48COLOPLAST CORP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Natakom Nash Chulamorkodt, MD?

Tedicare shows public-source Medicare data for Natakom Nash Chulamorkodt, MD (NPI 1043388481), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Natakom Nash Chulamorkodt, MD have ACO affiliation data?

Natakom Nash Chulamorkodt, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Natakom Nash Chulamorkodt, MD?

Natakom Nash Chulamorkodt, MD is linked to YUMA UROLOGY CENTER PLLC (billing NPI 1841482577) in the available physician profile data.

Does Natakom Nash Chulamorkodt, MD have Open Payments data?

Natakom Nash Chulamorkodt, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.